TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Triazole Pharmaceutical Compounds, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Triazole Pharmaceutical Compounds technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Triazole Pharmaceutical Compounds

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jul 31, 2025
CompanyTotal Oppositions
NOVARTIS6
PIERRE FABRE DERMO COSMTIQUE1

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Triazole Pharmaceutical Compounds industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Triazole Pharmaceutical Compounds industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Triazole Pharmaceutical Compounds industry

Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or RemodelingNOVARTISJan 28, 2022STADA ARZNEIMITTEL
Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or RemodelingNOVARTISJan 27, 2022TEVA PHARMACEUTICALS
Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or RemodelingNOVARTISJan 26, 2022ALFRED E TIEFENBACHER
Composition And Association Of Sunscreens For Photostabilizing Butyl Methoxydibenzoylmethane (Bmdbm)PIERRE FABRE DERMO COSMTIQUEAug 10, 2018BEIERSDORF

To stay ahead in the competitive Triazole Pharmaceutical Compounds industry, companies are constantly innovating. Here are the top patents facing oppositions in the Triazole Pharmaceutical Compounds industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Apr 28, 2021Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or RemodelingNOVARTIS6
Nov 15, 2017Composition And Association Of Sunscreens For Photostabilizing Butyl Methoxydibenzoylmethane (Bmdbm)PIERRE FABRE DERMO COSMTIQUE1